Naftin Gel
Product Images NDC 54766-772

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naftin (NDC 54766-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ca77245001

Ca77245001
NAFTIN Gel is a medication containing Naftifine Hydrochloride for topical use for the treatment of fungal skin infections. It is intended for external use only on the affected skin areas. The medication comes in a gel form and is commonly used for dermatological issues. The text also includes some unclear characters and errors.*
FDA Label Image

Ca77260001

Ca77260001
NAFTIN Gel is a topical medication containing Naftifine Hydrochloride in a 60g tube. It is not suitable for ophthalmic, oral, or intravaginal use. The product should only be used as directed for skin conditions.*
FDA Label Image

Chemical Structure (Naftin 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.